Stock ScreenerStock IdeasStock ForecastsStock Predictions & Stock Market Forecast 2025, 2026, 2027, 2028, 2029View analyst forecasts, price targets, buy/sell ratings, revenue/earnings forecasts and more
Stock ScreenerStock IdeasStock Forecasts
| Ticker | Company | Zen Rating | Growth | Market Cap | Revenue | EBITDA | Earnings | EPS | Rev. Y/Y | Rev. 5Y | Earn. Y/Y | Earn. 5Y | Earnings Date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| LAFAU | LAFAYETTE ACQUISITION CORP | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |||
| EFTY | ETOILES CAPITAL GROUP CO LTD | N/A | $2.53M | $1.08M | $852.50k | $0.05 | 3,855.20% | N/A | 2,200.00% | N/A | |||
| KLAR | KLARNA GROUP PLC | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | 2025-11-18 | ||
| DKI | DARKIRIS INC | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |||
| STKE | SOL STRATEGIES INC | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |||
| CHECU | CHENGHE ACQUISITION III CO | N/A | $0.00 | -$75.85k | -$75.85k | -$0.02 | N/A | N/A | N/A | N/A | |||
| YCY.U | AA MISSION ACQUISITION CORP II | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |||
| DMIIU | DRUGS MADE IN AMERICA ACQUISITION II CORP | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |||
| LKSPU | LAKE SUPERIOR ACQUISITION CORP | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |||
| DLXY | DELIXY HOLDINGS LTD | N/A | $314.92M | $1.19M | $1.03M | $0.07 | 8.90% | N/A | -12.50% | N/A | |||
| LBRX | LB PHARMACEUTICALS INC | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |||
| EMPG | EMPRO GROUP INC | N/A | $5.48M | $1.51M | $751.36k | $0.11 | 48.37% | N/A | N/A | N/A | |||
| CEPF | CANTOR EQUITY PARTNERS IV INC | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |||
| NSRX | NASUS PHARMA LTD | N/A | $0.00 | -$1.50M | -$1.53M | -$0.22 | N/A | N/A | N/A | N/A | |||
| AEXA | AMERICAN EXCEPTIONALISM ACQUISITION CORP A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.